848 related articles for article (PubMed ID: 34661278)
21. Early treatment versus expectant management of hemodynamically significant patent ductus arteriosus for preterm infants.
Mitra S; Scrivens A; von Kursell AM; Disher T
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013278. PubMed ID: 33301630
[TBL] [Abstract][Full Text] [Related]
22. Surfactant therapy guided by tests for lung maturity in preterm infants at risk of respiratory distress syndrome.
Sibrecht G; Kearl CR; Borys F; Morariu M; Bruschettini M; Soll R
Cochrane Database Syst Rev; 2023 Oct; 10(10):CD013158. PubMed ID: 37882216
[TBL] [Abstract][Full Text] [Related]
23. Early (< 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.
Doyle LW; Cheong JL; Hay S; Manley BJ; Halliday HL
Cochrane Database Syst Rev; 2021 Oct; 10(10):CD001146. PubMed ID: 34674229
[TBL] [Abstract][Full Text] [Related]
24. Systemic corticosteroid regimens for prevention of bronchopulmonary dysplasia in preterm infants.
Onland W; De Jaegere AP; Offringa M; van Kaam A
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD010941. PubMed ID: 28141913
[TBL] [Abstract][Full Text] [Related]
25. Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome.
Stevens TP; Harrington EW; Blennow M; Soll RF
Cochrane Database Syst Rev; 2007 Oct; 2007(4):CD003063. PubMed ID: 17943779
[TBL] [Abstract][Full Text] [Related]
26. Indomethacin for symptomatic patent ductus arteriosus in preterm infants.
Evans P; O'Reilly D; Flyer JN; Soll R; Mitra S
Cochrane Database Syst Rev; 2021 Jan; 1(1):CD013133. PubMed ID: 33448032
[TBL] [Abstract][Full Text] [Related]
27. Late (≥ 7 days) inhaled corticosteroids to reduce bronchopulmonary dysplasia in preterm infants.
Onland W; Offringa M; van Kaam A
Cochrane Database Syst Rev; 2022 Dec; 12(12):CD002311. PubMed ID: 36521169
[TBL] [Abstract][Full Text] [Related]
28. Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure (NCPAP) for preterm neonates after extubation.
Lemyre B; Deguise MO; Benson P; Kirpalani H; De Paoli AG; Davis PG
Cochrane Database Syst Rev; 2023 Jul; 7(7):CD003212. PubMed ID: 37497794
[TBL] [Abstract][Full Text] [Related]
29. Methylxanthine for the prevention and treatment of apnea in preterm infants.
Marques KA; Bruschettini M; Roehr CC; Davis PG; Fiander M; Soll R
Cochrane Database Syst Rev; 2023 Oct; 10(10):CD013830. PubMed ID: 37905735
[TBL] [Abstract][Full Text] [Related]
30. Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure (NCPAP) for preterm neonates after extubation.
Lemyre B; Davis PG; De Paoli AG; Kirpalani H
Cochrane Database Syst Rev; 2017 Feb; 2(2):CD003212. PubMed ID: 28146296
[TBL] [Abstract][Full Text] [Related]
31. Postnatal phenobarbital for the prevention of intraventricular haemorrhage in preterm infants.
Romantsik O; Smit E; Odd DE; Bruschettini M
Cochrane Database Syst Rev; 2023 Mar; 3(3):CD001691. PubMed ID: 36924438
[TBL] [Abstract][Full Text] [Related]
32. Early nasal intermittent positive pressure ventilation (NIPPV) versus early nasal continuous positive airway pressure (NCPAP) for preterm infants.
Lemyre B; Laughon M; Bose C; Davis PG
Cochrane Database Syst Rev; 2016 Dec; 12(12):CD005384. PubMed ID: 27976361
[TBL] [Abstract][Full Text] [Related]
33. Corticosteroids for the prevention and treatment of bronchopulmonary dysplasia: an overview of systematic reviews.
van de Loo M; van Kaam A; Offringa M; Doyle LW; Cooper C; Onland W
Cochrane Database Syst Rev; 2024 Apr; 4(4):CD013271. PubMed ID: 38597338
[TBL] [Abstract][Full Text] [Related]
34. Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal health outcomes.
Walters A; McKinlay C; Middleton P; Harding JE; Crowther CA
Cochrane Database Syst Rev; 2022 Apr; 4(4):CD003935. PubMed ID: 35377461
[TBL] [Abstract][Full Text] [Related]
35. Inositol in preterm infants at risk for or having respiratory distress syndrome.
Howlett A; Ohlsson A; Plakkal N
Cochrane Database Syst Rev; 2019 Jul; 7(7):CD000366. PubMed ID: 31283839
[TBL] [Abstract][Full Text] [Related]
36. Effect of timing of umbilical cord clamping and other strategies to influence placental transfusion at preterm birth on maternal and infant outcomes.
Rabe H; Gyte GM; Díaz-Rossello JL; Duley L
Cochrane Database Syst Rev; 2019 Sep; 9(9):CD003248. PubMed ID: 31529790
[TBL] [Abstract][Full Text] [Related]
37. Association of Noninvasive Ventilation Strategies With Mortality and Bronchopulmonary Dysplasia Among Preterm Infants: A Systematic Review and Meta-analysis.
Isayama T; Iwami H; McDonald S; Beyene J
JAMA; 2016 Aug; 316(6):611-24. PubMed ID: 27532916
[TBL] [Abstract][Full Text] [Related]
38. Doxapram for the prevention and treatment of apnea in preterm infants.
Evans S; Avdic E; Pessano S; Fiander M; Soll R; Bruschettini M
Cochrane Database Syst Rev; 2023 Oct; 10(10):CD014145. PubMed ID: 37877431
[TBL] [Abstract][Full Text] [Related]
39. Enteral zinc supplementation for prevention of morbidity and mortality in preterm neonates.
Staub E; Evers K; Askie LM
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD012797. PubMed ID: 33710626
[TBL] [Abstract][Full Text] [Related]
40. Caffeine dosing regimens in preterm infants with or at risk for apnea of prematurity.
Bruschettini M; Brattström P; Russo C; Onland W; Davis PG; Soll R
Cochrane Database Syst Rev; 2023 Apr; 4(4):CD013873. PubMed ID: 37040532
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
